best glp 1 company for weight loss GLP-1 Medications Amazon One Medical GLP-1 management

The Type 2 Diabetes Mellitus segment accounted for the maximum share of over 55.5% by application in 2025 due to the high global disease burden resulting in rising demand for efficacious therapies for glycemic control

As new therapies and strategies emerge, they offer hope for improved quality of life and outcomes for patients struggling with obesity and associated chronic diseases, she said

Additionally, long-acting liraglutide and ultralong-acting semaglutide can mitigate the risk of adverse cardiovascular events in T2DM patients, whereas exenatide has no substantial effect on the incidence of adverse cardiovascular events (60)

Glick, Z